More honey recalled over undeclared ingredient to treat erectile dysfunction in product

0

MKS Enterprise LLC is recalling Dose Vital VIP Vital Honey after the product was found to contain the undeclared active pharmaceutical ingredient tadalafil, an FDA-approved prescription drug used to treat erectile dysfunction (ED).

The recall was initiated after FDA laboratory analysis confirmed that Dose Vital VIP Vital Honey contains the undeclared active pharmaceutical ingredient Tadalafil.

The FDA issued a warning letter to the company, along with three other honey companies, about the presence of active drug ingredients in their products. Shopaax.com also recalled all lots of Kingdom Honey Royal Honey VIP for containing undeclared sildenafil last week.

FDA approval of Viagra is limited to use under the supervision of a licensed healthcare professional. Use of products containing the undeclared active ingredient may pose a threat to consumers because the active ingredient may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure. life-threatening blood pressure. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Of the adult male population most likely to use these products, adult males who use nitrates for heart problems have the highest exposure to these products.

Recalled product:

  • The product was sold on wholesaleonline1.com, from March to July 2022, and distributed in all US states.
  • The product comes in a black box and contains 12 sachets of 15 grams of honey with different expiry dates stamped on the back.

To date, wholesaleonline1.com has not received any adverse event reports related to this recall.

Consumers who purchased the recalled product should immediately stop using it and return the recalled product for a full refund to: MKS Enterprise, LLC, 59 Paulison Ave. Passaic, NJ 07055.

Have you had a reaction to this product?

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch adverse event reporting program either online, by regular mail, or by fax.

  • Complete and submit the report On line
  • Ordinary mail or fax: Download the form or call 1-800-332-1088 to request a report form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

(To sign up for a free subscription to Food Safety News, Click on here)

Share.

Comments are closed.